Thank you for subscribing!
Next Investors Sep 02, 2023
In this Weekender, we announce an upcoming portfolio addition on Monday at 10am AEST (4th September 2023) and look at the current stage the small caps market is on the business cycle.
Finfeed Archived Apr 16, 2020
Mayne Pharma Group Limited (ASX: MYX) has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA), seeking marketing authorisation for E4/DRSP, a combined oral contraceptive indicated for the prevention of pregnancy.
Finfeed Archived Feb 28, 2020
Antisense Therapeutics Limited (ASX:ANP) has appointed Gil Price M.D. as Consultant Medical Director. Dr. Price is a clinical physician trained in internal medicine with a long-standing focus in drug development, adverse drug reactions, drug utilization and regulation.
Get expert stock analysis direct in your inbox
Join Our Mailing List
